# Study of FTY720 in Patients With Uveitis

> **NCT01791192** · PHASE2 · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Acute Noninfectious Posterior, Intermediate, or Pan Uveitis

## Interventions

- **DRUG:** FTY720
- **DRUG:** Oral Corticosteroid

## Key facts

- **NCT ID:** NCT01791192
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-11
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01791192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01791192, "Study of FTY720 in Patients With Uveitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01791192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*